Ekablad et al. [39] indicated that the plasma ghrelin levels were significantly higher in patients with MEN1 syndrome tumors, as compared to the group of patients with sporadic tumors. The gene discussed is GHRL; the disease is multiple endocrine neoplasia type 1.